KATP channels and cardiovascular disease: Suddenly a syndrome

Circulation Research

Volumn 112, Issue 7, 2013, Pages 1059-1072

  Nichols, Colin G ^a   Singh, Gautam K ^b   Grange, Dorothy K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pediatrics ^*  (United States)

Author keywords

arrhythmias, cardiac; Cantu syndrome; edema; Kir6.1 protein, human; Kir6.2 channel; SUR2 receptor, human; vasodilation

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL;

CANTU SYNDROME; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CHONDRODYSPLASIA; CRANIOFACIAL MALFORMATION; ELECTROCARDIOGRAM; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTRICHOSIS; LOSS OF FUNCTION MUTATION; LYMPHEDEMA; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PERICARDIAL EFFUSION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; HEART; HEART ARRHYTHMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; X CHROMOSOME LINKED DISORDER;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMEGALY; GENETIC DISEASES, X-LINKED; HEART; HUMANS; HYPERTRICHOSIS; KATP CHANNELS; OSTEOCHONDRODYSPLASIAS;

MLCS; MLOWN;

EID: 84876358672     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.300514     Document Type: Review

References (188)

1. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983;305:147-148.
2. Flagg TP, Enkvetchakul D, Koster JC, Nichols CG. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev. 2010;90:799-829.
3. Kane GC, Liu XK, Yamada S, Olson TM, Terzic A. Cardiac KATP channels in health and disease. J Mol Cell Cardiol. 2005;38:937-943.
4. Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron. 1996;16:1011-1017.
5. Inagaki N, Gonoi T, Clement JPt, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. Reconstitution of IKATP: an inward rectifer subunit plus the sulfonylurea receptor [see comments]. Science. 1995;270:1166-1170.
6. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III, González G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA. Cloning of the beta cell high-affnity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
7. Chutkow WA, Simon MC, Le Beau MM, Burant CF. Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes. 1996;45:1439-1445.
8. Shi Y, Wu Z, Cui N, Shi W, Yang Y, Zhang X, Rojas A, Ha BT, Jiang C. PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1205-R1214.
9. Chutkow WA, Makielski JC, Nelson DJ, Burant CF, Fan Z. Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J Biol Chem. 1999;274:13656-13665.
10. Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. Reconstitution of IKATP: an inward rectifer subunit plus the sulfonylurea receptor. Science. 1995;270:1166-1170.
11. Shyng S, Nichols CG. Octameric stoichiometry of the KATP channel complex. J Gen Physiol. 1997;110:655-664.
12. Clement JPt, Kunjilwar K, Gonzalez G, Schwanstecher M, Panten U, Aguilar-Bryan L, Bryan J. Association and stoichiometry of K(ATP) channel subunits. Neuron. 1997;18:827-838.
13. Inagaki N, Gonoi T, Seino S. Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel. FEBS Lett. 1997;409:232-236.
14. Yamada M, Isomoto S, Matsumoto S, Kondo C, Shindo T, Horio Y, Kurachi Y. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J Physiol (Lond). 1997;499 (Pt 3):715-720.
15. Okuyama Y, Yamada M, Kondo C, Satoh E, Isomoto S, Shindo T, Horio Y, Kitakaze M, Hori M, Kurachi Y. The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells. Pfugers Arch. 1998;435:595-603.
16. Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res. 1998;83:1132-1143.
17. Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, Doyle DA. Crystal structure of the potassium channel KirBac1.1 in the closed state. Science. 2003;300:1922-1926.
18. Tao X, Avalos JL, Chen J, MacKinnon R. Crystal structure of the eu-karyotic strong inward-rectifer K+ channel Kir2.2 at 3.1 A resolution. Science. 2009;326:1668-1674.
19. Bryan J, Vila-Carriles WH, Zhao G, Babenko AP, Aguilar-Bryan L. Toward linking structure with function in ATP-sensitive K+ channels. Diabetes. 2004;(53 Suppl 3):S104-S112.
20. Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature. 2006;440:470-476.
21. Mikhailov MV, Campbell JD, de Wet H, Shimomura K, Zadek B, Collins RF, Sansom MS, Ford RC, Ashcroft FM. 3-D structural and functional characterization of the purifed KATP channel complex Kir6.2-SUR1. EMBO J. 2005;24:4166-4175.
22. Wang S, Makhina EN, Masia R, Hyrc KL, Formanack ML, Nichols CG. Domain organization of the ATP-sensitive potassium channel complex examined by FRET. J Biol Chem. 2013;288:4378-4388.
23. Nichols CG, Makhina EN, Pearson WL, Sha Q, Lopatin AN. Inward rec-tifcation and implications for cardiac excitability. Circ Res. 1996;78:1-7.
24. Béguin P, Nagashima K, Nishimura M, Gonoi T, Seino S. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J. 1999;18:4722-4732.
25. Morrissey A, Rosner E, Lanning J, Parachuru L, Dhar Chowdhury P, Han S, Lopez G, Tong X, Yoshida H, Nakamura TY, Artman M, Giblin JP, Tinker A, Coetzee WA. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol. 2005;5:1.
26. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifer Kir6.1. Nat Med. 2002;8:466-472.
27. Cheng WW, Tong A, Flagg TP, Nichols CG. Random assembly of SUR subunits in K(ATP) channel complexes. Channels (Austin). 2008;2:34-38.
28. Chan KW, Wheeler A, Csanády L. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition. J Gen Physiol. 2008;131:43-58.
29. Wheeler A, Wang C, Yang K, Fang K, Davis K, Styer AM, Mirshahi U, Moreau C, Revilloud J, Vivaudou M, Liu S, Mirshahi T, Chan KW. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels. Mol Pharmacol. 2008;74:1333-1344.
30. Cui Y, Giblin JP, Clapp LH, Tinker A. A mechanism for ATP-sensitive potassium channel diversity: Functional coassembly of two pore-forming subunits. Proc Natl Acad Sci USA. 2001;98:729-734.
31. Pountney DJ, Sun ZQ, Porter LM, Nitabach MN, Nakamura TY, Holmes D, Rosner E, Kaneko M, Manaris T, Holmes TC, Coetzee WA. Is the molecular composition of K(ATP) channels more complex than originally thought? J Mol Cell Cardiol. 2001;33:1541-1546.
32. Kono Y, Horie M, Takano M, Otani H, Xie LH, Akao M, Tsuji K, Sasayama S. The properties of the Kir6.1-6.2 tandem channel co-expressed with SUR2A. Pfugers Arch Eur J Physiol. 2000;440: 692-698.
33. Glukhov AV, Flagg TP, Fedorov VV, Efmov IR, Nichols CG. Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol. 2010;48:152-160.
34. Flagg TP, Kurata HT, Masia R, Caputa G, Magnuson MA, Lefer DJ, Coetzee WA, Nichols CG. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1. Circ Res. 2008;103:1458-1465.
35. Fedorov V V, Glukhov AV, Ambrosi CM, Kostecki G, Chang R, Janks D, Schuessler RB, Moazami N, Nichols CG, Efmov IR. Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol. 2011;51:215-225.
36. Han X, Light PE, Giles WR, French RJ. Identifcation and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells. J Physiol (Lond). 1996;490(Pt 2):337-350.
37. Kakei M, Noma A. Adenosine-5'-triphosphate-sensitive single potassium channel in the atrioventricular node cell of the rabbit heart. J Physiol (Lond). 1984;352:265-284.
38. Light PE, Cordeiro JM, French RJ. Identifcation and properties of ATP-sensitive potassium channels in myocytes from rabbit Purkinje fbres. Cardiovasc Res. 1999;44:356-369.
39. Fukuzaki K, Sato T, Miki T, Seino S, Nakaya H. Role of sarcolemmal ATP-sensitive K+ channels in the regulation of sinoatrial node auto-maticity: an evaluation using Kir6.2-defcient mice. J Physiol (Lond). 2008;586:2767-2778.
40. Dart C, Standen NB. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J Physiol (Lond). 1993;471:767-786.
41. Nichols CG, Lederer WJ. The regulation of ATP-sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. J Physiol (Lond). 1990;423:91-110.
42. Blanco-Rivero J, Gamallo C, Aras-López R, Cobeño L, Cogolludo A, Pérez-Vizcaino F, Ferrer M, Balfagon G. Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels. Eur J Pharmacol. 2008;587:204-208.
43. Cui Y, Tran S, Tinker A, Clapp LH. The molecular composition of K(ATP) channels in human pulmonary artery smooth muscle cells and their modulation by growth. Am J Respir Cell Mol Biol. 2002;26: 135-143.
44. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989;245:177-180.
45. Miyoshi Y, Nakaya Y, Wakatsuki T, Nakaya S, Fujino K, Saito K, Inoue I. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res. 1992;70: 612-616.
46. Ottolia M, Toro L. Reconstitution in lipid bilayers of an ATP-sensitive K+ channel from pig coronary smooth muscle. J Membr Biol. 1996;153:203-209.
47. Beech DJ, Zhang H, Nakao K, Bolton TB. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol. 1993;110:573-582.
48. Kajioka S, Kitamura K, Kuriyama H. Guanosine diphosphate activates an adenosine 5'-triphosphate-sensitive K+ channel in the rabbit portal vein. J Physiol (Lond). 1991;444:397-418.
49. Kamouchi M, Kitamura K. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein. Am J Physiol. 1994;266:H1687-H1698.
50. Miyoshi Y, Nakaya Y. Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun. 1991;181:700-706.
51. Wakatsuki T, Nakaya Y, Inoue I. Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol. 1992;263:H491-H496.
52. Furspan PB, Webb RC. Decreased ATP sensitivity of a K+ channel and enhanced vascular smooth muscle relaxation in genetically hypertensive rats. J Hypertens. 1993;11:1067-1072.
53. Zhang HL, Bolton TB. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol. 1996;118:105-114.
54. Cole WC, Malcolm T, Walsh MP, Light PE. Inhibition by protein kinase C of the K(NDP) subtype of vascular smooth muscle ATP-sensitive potassium channel. Circ Res. 2000;87:112-117.
55. Cole WC, Clément-Chomienne O. ATP-sensitive K+ channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol. 2003;14:94-103.
56. Aguilar-Bryan L, Nichols CG, Rajan AS, Parker C, Bryan J. Co-expression of sulfonylurea receptors and KATP channels in hamster insulinoma tumor (HIT) cells. Evidence for direct association of the receptor with the channel. J Biol Chem. 1992;267:14934-14940.
57. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature. 1984;312:446-448.
58. Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. Reconstitution of IKATP: an inward rectifer subunit plus the sulfonylurea receptor. Science. 1995;270:1166-1170.
59. Farzaneh T, Tinker A. Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 sub-units. Cardiovasc Res. 2008;79:621-631.
60. Isomoto S, Kondo C, Yamada M, Matsumoto S, Higashiguchi O, Horio Y, Matsuzawa Y, Kurachi Y. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem. 1996;271:24321-24324.
61. Satoh E, Yamada M, Kondo C, Repunte VP, Horio Y, Iijima T, Kurachi Y. Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modifcation by pinacidil. J Physiol (Lond). 1998;511(Pt 3):663-674.
62. Babenko AP, Bryan J. A conserved inhibitory and differential stimulatory action of nucleotides on K(IR)6.0/SUR complexes is essential for excitation-metabolism coupling by K(ATP) channels. J Biol Chem. 2001;276:49083-49092.
63. Trube G, Hescheler J. Inward-rectifying channels in isolated patches of the heart cell membrane: ATP-dependence and comparison with cell-attached patches. Pfugers Arch. 1984;401:178-184.
64. Janigro D, West GA, Gordon EL, Winn HR. ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol. 1993;265:C812-C821.
65. Malester B, Tong X, Ghiu I, Kontogeorgis A, Gutstein DE, Xu J, Hendricks-Munoz KD, Coetzee WA. Transgenic expression of a dominant negative KATP channel subunit in the mouse endothelium: effects on coronary fow and endothelin-1 secretion. Faseb J. 2007 Mar 6 [Epub ahead of print].
66. Katnik C, Adams DJ. An ATP-sensitive potassium conductance in rabbit arterial endothelial cells. J Physiol (Lond). 1995;485(Pt 3):595-606.
67. Katnik C, Adams DJ. Characterization of ATP-sensitive potassium channels in freshly dissociated rabbit aortic endothelial cells. Am J Physiol. 1997;272:H2507-H2511.
68. Mederos y Schnitzler M, Derst C, Daut J, Preisig-Muller R. ATP-sensitive potassium channels in capillaries isolated from guinea-pig heart. J Physiol. 2000;525 (Pt 2):307-317.
69. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
70. Paucek P, Yarov-Yarovoy V, Sun X, Garlid KD. Inhibition of the mito-chondrial KATP channel by long-chain acyl-CoA esters and activation by guanine nucleotides. J Biol Chem. 1996;271:32084-32088.
71. Garlid KD, Paucek P, Yarov-Yarovoy V, Sun X, Schindler PA. The mito-chondrial KATP channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
72. Liu Y, Ren G, O'Rourke B, Marbán E, Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defned surface K(ATP) channels. Mol Pharmacol. 2001;59:225-230.
73. Hu H, Sato T, Seharaseyon J, Liu Y, Johns DC, O'Rourke B, Marbán E. Pharmacological and histochemical distinctions between molecularly defned sarcolemmal KATP channels and native cardiac mitochondrial KATP channels. Mol Pharmacol. 1999;55:1000-1005.
74. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marbán E, Nakaya H. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002;109:509-516.
75. Cuong DV, Kim N, Joo H, Youm JB, Chung JY, Lee Y, Park WS, Kim E, Park YS, Han J. Subunit composition of ATP-sensitive potassium channels in mitochondria of rat hearts. Mitochondrion. 2005;5:121-133.
76. Zhou M, Tanaka O, Sekiguchi M, He HJ, Yasuoka Y, Itoh H, Kawahara K, Abe H. ATP-sensitive K(+)-channel subunits on the mitochondria and endoplasmic reticulum of rat cardiomyocytes. Journal of Histochemical Cytochemistry. 2005 Jun 27 [Epub ahead of print].
77. Singh H, Hudman D, Lawrence CL, Rainbow RD, Lodwick D, Norman RI. Distribution of Kir6.0 and SUR2 ATP-sensitive potassium channel subunits in isolated ventricular myocytes. J Mol Cell Cardiol. 2003;35:445-459.
78. Suzuki M, Kotake K, Fujikura K, Inagaki N, Suzuki T, Gonoi T, Seino S, Takata K. Kir6.1: a possible subunit of ATP-sensitive K+ channels in mitochondria. Biochem Biophys Res Commun. 1997;241:693-697.
79. Foster DB, Rucker JJ, Marbán E. Is Kir6.1 a subunit of mitoK(ATP)? Biochem Biophys Res Commun. 2008;366:649-656.
80. Chutkow WA, Samuel V, Hansen PA, Pu J, Valdivia CR, Makielski JC, Burant CF. Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci USA. 2001;98:11760-11764.
81. Pu J, Wada T, Valdivia C, Chutkow WA, Burant CF, Makielski JC. Evidence of KATP channels in native cardiac cells without SUR. Biophysical J. 2001;80:625a-626a.
82. Pu JL, Ye B, Kroboth SL, McNally EM, Makielski JC, Shi NQ. Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide- insensitive K(ATP) activity. J Mol Cell Cardiol. 2008;44:188-200.
83. Ye B, Kroboth SL, Pu JL, Sims JJ, Aggarwal NT, McNally EM, Makielski JC, Shi NQ. Molecular identifcation and functional characterization of a mitochondrial sulfonylurea receptor 2 splice variant generated by intraexonic splicing. Circ Res. 2009;105:1083-1093.
84. Elrod JW, Harrell M, Flagg TP, Gundewar S, Magnuson MA, Nichols CG, Coetzee WA, Lefer DJ. Role of sulfonylurea receptor type 1 sub-units of ATP-sensitive potassium channels in myocardial ischemia/reper-fusion injury. Circulation. 2008;117:1405-1413.
85. Stoller DA, Fahrenbach JP, Chalupsky K, Tan BH, Aggarwal N, Metcalfe J, Hadhazy M, Shi NQ, Makielski JC, McNally EM. Cardiomyocyte sulfonylurea receptor 2-KATP channel mediates cardioprotection and ST segment elevation. Am J Physiol Heart Circ Physiol. 2010;299:H1100-H1108.
86. Aggarwal NT, Pravdic D, McNally EM, Bosnjak ZJ, Shi NQ, Makielski JC. The mitochondrial bioenergetic phenotype for protection from cardiac ischemia in SUR2 mutant mice. Am J Physiol Heart Circ Physiol. 2010;299:H1884-H1890.
87. Hanley PJ, Mickel M, Löffer M, Brandt U, Daut J. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol (Lond). 2002;542:735-741.
88. Ardehali H, Chen Z, Ko Y, Mejía-Alvarez R, Marbán E. Multiprotein complex containing succinate dehydrogenase confers mitochon-drial ATP-sensitive K+ channel activity. Proc Natl Acad Sci USA. 2004;101:11880-11885.
89. Ardehali H, O'Rourke B, Marbán E. Cardioprotective role of the mitochondrial ATP-binding cassette protein 1. Circ Res. 2005;97: 740-742.
90. Foster DB, Ho AS, Rucker JJ, Garlid AO, Chen L, Sidor A, Garlid KD, O'Rourke B. Mitochondrial ROMK Channel Is a Molecular Component of MitoKATP. Circ Res. 2012;111:446-454.
91. Lederer WJ, Nichols CG, Smith GL. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol (Lond). 1989;413:329-349.
92. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
93. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990;259:C3-C18.
94. Nelson MT, Standen NB, Brayden JE, Worley JF III. Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature. 1988;336:382-385.
95. Daut J, Standen NB, Nelson MT. The role of the membrane potential of endothelial and smooth muscle cells in the regulation of coronary blood fow. J Cardiovasc Electrophysiol. 1994;5:154-181.
96. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol. 2004;31:641-649.
97. Miki T, Seino S. Roles of KATP channels as metabolic sensors in acute metabolic changes. J Mol Cell Cardiol. 2005;38:917-925.
98. Nichols CG, Koster JC, Remedi MS. beta-cell hyperexcitability: from hyperinsulinism to diabetes. Diabetes Obes Metab. 2007;9(Suppl 2):81-88.
99. Bao L, Kefaloyianni E, Lader J, Hong M, Morley G, Fishman GI, Sobie EA, Coetzee WA. Unique properties of the ATP-sensitive K+ channel in the mouse ventricular cardiac conduction system. Circ Arrhythm Electrophysiol. 2011;4:926-935.
100. Haïssaguerre M, Chatel S, Sacher F, Weerasooriya R, Probst V, Loussouarn G, Horlitz M, Liersch R, Schulze-Bahr E, Wilde A, Kääb S, Koster J, Rudy Y, Le Marec H, Schott JJ. Ventricular fbrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol. 2009;20:93-98.
101. Delaney JT, Muhammad R, Blair MA, Kor K, Fish FA, Roden DM, Darbar D. A KCNJ8 mutation associated with early repolarization and atrial fbrillation. Europace. 2012;14:1428-1432.
102. Medeiros-Domingo A, Tan BH, Crotti L, Tester DJ, Eckhardt L, Cuoretti A, Kroboth SL, Song C, Zhou Q, Kopp D, Schwartz PJ, Makielski JC, Ackerman MJ. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm. 2010;7:1466-1471.
103. Barajas-Martínez H, Hu D, Ferrer T, et al. Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm. 2012;9:548-555.
104. Tester DJ, Tan BH, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011;4:510-515.
105. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006;355:456-466.
106. Proks P, Arnold AL, Bruining J, Girard C, Flanagan SE, Larkin B, Colclough K, Hattersley AT, Ashcroft FM, Ellard S. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet. 2006;15:1793-1800.
107. Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, Edghill EL, Mackay DJ, Proks P, Shimomura K, Haberland H, Carson DJ, Shield JP, Hattersley AT, Ashcroft FM. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81:375-382.
108. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE, Terzic A. ABCC9 mutations identifed in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet. 2004;36:382-387.
109. Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, Seino S, Asirvatham SJ, Jahangir A, Terzic A. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fbrillation. Nat Clin Pract Cardiovasc Med. 2007;4:110-116.
110. van Bon BW, Gilissen C, Grange DK, et al. Cantú syndrome is caused by mutations in ABCC9. Am J Hum Genet. 2012;90:1094-1101.
111. Cantú JM, García-Cruz D, Sánchez-Corona J, Hernández A, Nazará Z. A distinct osteochondrodysplasia with hypertrichosis-Individualization of a probable autosomal recessive entity. Hum Genet. 1982;60:36-41.
112. Grange DK, Lorch SM, Cole PL, Singh GK. Cantu syndrome in a woman and her two daughters: Further confrmation of autosomal dominant inheritance and review of the cardiac manifestations. Am J Med Genet A. 2006;140:1673-1680.
113. Harakalova M, van Harssel JJ, Terhal PA, et al. Dominant missense mutations in ABCC9 cause Cantú syndrome. Nat Genet. 2012;44:793-796.
114. Scurr I, Wilson L, Lees M, Robertson S, Kirk E, Turner A, Morton J, Kidd A, Shashi V, Stanley C, Berry M, Irvine AD, Goudie D, Turner C, Brewer C, Smithson S. Cantu syndrome: report of nine new cases and expansion of the clinical phenotype. Am J Med Genet A.155A:508-518.
115. García-Cruz D, Mampel A, Echeverria MI, et al. Cantu syndrome and lymphoedema. Clin Dysmorphol. 2011;20:32-37.
116. Kobayashi D, Cook AL, Williams DA. Pulmonary hypertension secondary to partial pulmonary venous obstruction in a child with Cantu syndrome. Pediatr Pulmonol. 2010;45:727-729.
117. Engels H, Bosse K, Ehrbrecht A, Zahn S, Hoischen A, Propping P, Bindl L, Reutter H. Further case of Cantú syndrome: exclusion of cryptic sub-telomeric chromosome aberrations. Am J Med Genet. 2002;111:205-209.
118. Lazalde B, Sánchez-Urbina R, Nuño-Arana I, Bitar WE, de Lourdes Ramírez-Dueñas M. Autosomal dominant inheritance in Cantú syndrome (congenital hypertrichosis, osteochondrodysplasia, and cardio-megaly). Am J Med. Genet. 2000;94:421-427.
119. Concolino D, Formicola S, Camera G, Strisciuglio P. Congenital hyper-trichosis, cardiomegaly, and osteochondrodysplasia (Cantú syndrome): a new case with unusual radiological fndings. Am J Med. Genet. 2000;92:191-194.
120. Robertson SP, Kirk E, Bernier F, Brereton J, Turner A, Bankier A. Congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly: Cantú syndrome. Am J Med. Genet. 1999;85:395-402.
121. Rosser EM, Kaariainen H, Hurst JA, Baraitser M, Hall CM, Clayton P, Leonard JV. Three patients with the osteochondrodysplasia and hy-pertrichosis syndrome-Cantu syndrome. Clin Dysmorphol. 1998;7: 79-85.
122. Nevin NC, Mulholland HC, Thomas PS. Congenital hypertrichosis, cardiomegaly and mild osteochondrodysplasia. Am J Med. Genet. 1996;66:33-38.
123. García-Cruz D, Mampel A, Echeverria MI, et al. Cantu syndrome and lymphoedema. Clin Dysmorphol. 2011;20:32-37.
124. Pennisi AJ, Takahashi M, Bernstein BH, Singsen BH, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Hanson V, Fine RN. Minoxidil therapy in children with severe hypertension. J Pediatr. 1977;90:813-819.
125. Mehta PK, Mamdani B, Shansky RM, Mahurkar SD, Dunea G. Severe hypertension. Treatment with minoxidil. JAMA. 1975;233: 249-252.
126. Meisheri KD, Cipkus LA, Taylor CJ. Mechanism of action of minoxi-dil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther. 1988;245:751-760.
127. Winquist RJ, Heaney LA, Wallace AA, Baskin EP, Stein RB, Garcia ML, Kaczorowski GJ. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther. 1989;248:149-156.
128. Kaler SG, Patrinos ME, Lambert GH, Myers TF, Karlman R, Anderson CL. Hypertrichosis and congenital anomalies associated with maternal use of minoxidil. Pediatrics. 1987;79:434-436.
129. Rosa FW, Idanpaan-Heikkila J, Asanti R. Fetal minoxidil exposure. Pediatrics. 1987;80:120.
130. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873-1882.
131. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Defnition and Classifcation of cardiomyopathies. Circulation. 1996;93:841-842.
132. Mehta PA, Dubrey SW. High output heart failure. QJM. 2009;102:235-241.
133. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Infamm Allergy Drug Discov. 2012;6:130-136.
134. Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J. 2008;22:1725-1736.
135. Seino S, Iwanaga T, Nagashima K, Miki T. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes. 2000;49:311-318.
136. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifer Kir6.1. Nat Med. 2002;8:466-472.
137. Chutkow WA, Pu J, Wheeler MT, Wada T, Makielski JC, Burant CF, McNally EM. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest. 2002;110:203-208.
138. Faivre JF, Findlay I. Effects of tolbutamide, glibenclamide and diazox-ide upon action potentials recorded from rat ventricular muscle. Biochim Biophys Acta. 1989;984:1-5.
139. Li RA, Leppo M, Miki T, Seino S, Marbán E. Molecular basis of electro-cardiographic ST-segment elevation. Circ Res. 2000;87:837-839.
140. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marbán E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarifed by Kir6.2-knockout mice. Circ Res. 2001;88:570-577.
141. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res. 1991;69:571-581.
142. Venkatesh N, Lamp ST, Weiss JN. Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res. 1991;69:623-637.
143. McPherson CD, Pierce GN, Cole WC. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. Am J Physiol. 1993;265:H1809-H1818.
144. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA. 2002;99:13278-13283.
145. Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S, Terzic A. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol (Lond). 2006;577:1053-1065.
146. Hu X, Xu X, Huang Y, Fassett J, Flagg TP, Zhang Y, Nichols CG, Bache RJ, Chen Y. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload. Circ Res. 2008;103:1009-1017.
147. Kane GC, Behfar A, Dyer RB, O'Cochlain DF, Liu XK, Hodgson DM, Reyes S, Miki T, Seino S, Terzic A. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006;15:2285-2297.
148. Stoller D, Kakkar R, Smelley M, Chalupsky K, Earley JU, Shi NQ, Makielski JC, McNally EM. Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress. J Mol Cell Cardiol. 2007;43:445-454.
149. Ellis JA, Lamantia A, Chavez R, Scurrah KJ, Nichols CG, Harrap SB. Genes controlling postural changes in blood pressure: comprehensive association analysis of ATP-sensitive potassium channel genes KCNJ8 and ABCC9. Physiol Genomics. 2010;40:184-188.
150. Duan R, Cui W, Wang H. Mutational analysis of the Kir6.1 gene in Chinese hypertensive patients treated with the novel ATP-sensitive potassium channel opener iptakalim. Exp Ther Med. 2011;2:757-760.
151. Harrap SB, Cui JS, Wong ZY, Hopper JL. Familial and genomic analyses of postural changes in systolic and diastolic blood pressure. Hypertension. 2004;43:586-591.
152. Yoshida H, Feig JE, Morrissey A, Ghiu IA, Artman M, Coetzee WA. K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits. J Mol Cell Cardiol. 2004;37:857-869.
153. Gendron ME, Thorin E, Perrault LP. Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy. Br J Pharmacol. 2004;143:285-291.
154. Kakkar R, Ye B, Stoller DA, Smelley M, Shi NQ, Galles K, Hadhazy M, Makielski JC, McNally EM. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res. 2006;98:682-689.
155. Nichols CG, Koster JC. Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab. 2002;283:E403-E412.
156. Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG. Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell. 2000;100:645-654.
157. Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350:1838-1849.
158. Flagg TP, Charpentier F, Manning-Fox J, Remedi MS, Enkvetchakul D, Lopatin A, Koster J, Nichols C. Remodeling of excitation-contraction coupling in transgenic mice expressing ATP-insensitive sarcolemmal KATP channels. Am J Physiol Heart Circ Physiol. 2004;286:H1361-H1369.
159. Rajashree R, Koster JC, Markova KP, Nichols CG, Hofmann PA. Contractility and ischemic response of hearts from transgenic mice with altered sarcolemmal K(ATP) channels. Am J Physiol Heart Circ Physiol. 2002;283:H584-H590.
160. Koster JC, Knopp A, Flagg TP, Markova KP, Sha Q, Enkvetchakul D, Betsuyaku T, Yamada KA, Nichols CG. Tolerance for ATP-insensitive K(ATP) channels in transgenic mice. Circ Res. 2001;89:1022-1029.
161. Flagg TP, Patton B, Masia R, Mansfeld C, Lopatin AN, Yamada KA, Nichols CG. Arrhythmia susceptibility and premature death in transgen-ic mice overexpressing both SUR1 and Kir6.2[DeltaN30, K185Q] in the heart. Am J Physiol Heart Circ Physiol. 2007;293:H836-H845.
162. Toib A, Zhang HX, Broekelmann TJ, Hyrc KL, Guo Q, Chen F, Remedi MS, Nichols CG. Cardiac specifc ATP-sensitive K+ channel (KATP) overexpression results in embryonic lethality. J Mol Cell Cardiol. 2012;53:437-445.
163. Masia R, Enkvetchakul D, Nichols C. Differential nucleotide regulation of K(ATP) channels by SUR1 and SUR2A. J Mol Cell Cardiol. 2005;39:491-501.
164. Goldberg MR. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels. J Cardiovasc Pharmacol. 1988;12(Suppl 2):S41-S47.
165. Buhl AE, Waldon DJ, Conrad SJ, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Brunden MN, Stefanski KJ, Stehle RG. Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol. 1992;98:315-319.
166. Avatapalle B, Banerjee I, Malaiya N, Padidela R. Echocardiography monitoring for diazoxide induced pericardial effusion. BMJ Case Rep. 2012;bcr0320126110.
167. Shanti B, Silink M, Bhattacharya K, Howard NJ, Carpenter K, Fietz M, Clayton P, Christodoulou J. Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase defciency. J Inherit Metab Dis. 2009;32 (Suppl 1):S241-S251.
168. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654-660.
169. Koster JC, Sha Q, Nichols CG. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol. 1999;114:203-213.
170. Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. 2011;32:1900-1908.
171. Gore MO, McGuire DK. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments. Eur Heart J. 2011;32:1832-1834.
172. Pearson ER, Flechtner I, Njølstad PR, et al; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfo-nylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355:467-477.
173. Billman GE, Englert HC, Schölkens BA. HMR 1883, a novel cardiose-lective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fbrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther. 1998;286:1465-1473.
174. Wirth KJ, Uhde J, Rosenstein B, Englert HC, Gögelein H, Schölkens BA, Busch AE. K(ATP) channel blocker HMR 1883 reduces monopha-sic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn Schmiedebergs Arch Pharmacol. 2000;361:155-160.
175. Manning Fox JE, Kanji HD, French RJ, Light PE. Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels. Br J Pharmacol. 2002;135: 480-488.
176. Weyermann A, Vollert H, Busch AE, Bleich M, Gögelein H. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:374-381.
177. Glukhov AV, Flagg TP, Fedorov VV, Efmov IR, Nichols CG. Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol. 2010;48:152-160.
178. Zhang HX, Akrouh A, Kurata HT, Remedi MS, Lawton JS, Nichols CG. HMR 1098 is not an SUR isotype specifc inhibitor of heterologous or sarcolemmal K ATP channels. J Mol Cell Cardiol. 2011;50:552-560.
179. Flagg TP, Nichols CG. Sarcolemmal K(ATP) channels: what do we really know? J Mol Cell Cardiol. 2005;39:61-70.
180. Flagg TP, Nichols CG. "Cardiac KATP": a family of ion channels. Circ Arrhythm Electrophysiol. 2011;4:796-798.
181. Neagoe I, Schwappach B. Pas de deux in groups of four-the biogenesis of KATP channels. J Mol Cell Cardiol. 2005;38:887-894.
182. Flanagan SE, Clauin S, Bellanné-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfo-nylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat. 2009;30:170-180.
183. Villareal DT, Koster JC, Robertson H, Akrouh A, Miyake K, Bell GI, Patterson BW, Nichols CG, Polonsky KS. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes. 2009;58:1869-1878.
184. Schwanstecher C, Meyer U, Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes. 2002;51: 875-879.
185. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfeld R, Wiltshire S, Turner RC. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med. 2001;18:206-212.
186. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia. 1998;41:1511-1515.
187. Inoue H, Ferrer J, Warren-Perry M, Zhang Y, Millns H, Turner RC, Elbein SC, Hampe CL, Suarez BK, Inagaki N, Seino S, Permutt MA. Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identifcation and lack of role in Caucasian patients with NIDDM. Diabetes. 1997;46:502-507.
188. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia. 1996;39:1233-1236.